000024142 000__ 01470cam\a2200493\i\4500
000024142 001__ 24142
000024142 003__ SzGeWIPO
000024142 005__ 20240708162219.0
000024142 008__ 080208s2001    nju|||||r|||| 00| 0 eng d
000024142 035__ $$a(wipo)0
000024142 035__ $$a(OCoLC)1161303867
000024142 040__ $$aSzGeWIPO$$beng$$erda$$cSzGeWIPO$$dCaBNVSL
000024142 041__ $$aeng
000024142 043__ $$af-sa---
000024142 050_4 $$aK1401.A15$$bJ68
000024142 08204 $$a346.048$$220
000024142 084__ $$aCH 51 Sep 2001 Vol. 4 No. 5
000024142 090__ $$c26401$$d26397
000024142 1001_ $$aKongolo, Tshimanga,
000024142 24510 $$aPublic interest versus the pharmaceutical industry's monopoly in South Africa.
000024142 264_1 $$aHoboken, New Jersey :$$bJohn Wiley & Sons, Inc.,$$c2001.
000024142 300__ $$a1 volume ([18] pages) ;$$c[28] cm.
000024142 336__ $$atext$$btxt$$2rdacontent
000024142 337__ $$aunmediated$$bn$$2rdamedia
000024142 338__ $$avolume$$bnc$$2rdacarrier
000024142 4901_ $$aThe Journal Of World Intellectual Property,$$x1422-2213 ;$$vSepages 2001, Vol. 4, No. 5, pages 609-627
000024142 650_0 $$aPatents (International law)
000024142 650_0 $$aIntellectual property (International law)
000024142 650_0 $$aCopyright, International.
000024142 650_0 $$aDispute resolution (Law)$$zCanada.
000024142 650_0 $$aIntellectual property$$zSouth Africa.
000024142 650_4 $$aPharmaceutical industry
000024142 650_4 $$aPatents
000024142 650_6 $$aDroit d'auteur international.
000024142 650_6 $$aBrevets d'invention$$xDroit international.
000024142 650_6 $$aPropriété intellectuelle (Droit international)
000024142 651_0 $$aSouth Africa$$xCommerce$$xLaw and legislation.
000024142 651_0 $$aAfrica$$xCommerce$$xLaw and legislation.
000024142 903__ $$aThe Journal of World Intellectual Property.
000024142 904__ $$aJournal article
000024142 942__ $$cART$$jCH 51 Sep 2001 Vol. 4 No. 5
000024142 952__ $$w2008-02-08$$p2008-0091$$u37738$$bMAIN$$10$$kCH 51 Sep 2001 Vol. 4 No. 5$$v2008-02-08$$71$$cLibrary$$yART
000024142 980__ $$aBIB
000024142 999__ $$c26401$$d26401